These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26079838)

  • 1. Bridge Technology with TSH Receptor Chimera for Sensitive Direct Detection of TSH Receptor Antibodies Causing Graves' Disease: Analytical and Clinical Evaluation.
    Frank CU; Braeth S; Dietrich JW; Wanjura D; Loos U
    Horm Metab Res; 2015 Nov; 47(12):880-8. PubMed ID: 26079838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
    Minich WB; Loos U
    Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
    Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
    Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
    Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
    Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
    Lenzner C; Morgenthaler NG
    Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease.
    Costagliola S; Morgenthaler NG; Hoermann R; Badenhoop K; Struck J; Freitag D; Poertl S; Weglöhner W; Hollidt JM; Quadbeck B; Dumont JE; Schumm-Draeger PM; Bergmann A; Mann K; Vassart G; Usadel KH
    J Clin Endocrinol Metab; 1999 Jan; 84(1):90-7. PubMed ID: 9920067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
    Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
    Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW; Lau KS; Kohn LD
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin receptor (mc4) is more useful in differentiation of Graves' disease from painless thyroiditis than conventional thyrotropin-stimulating antibody assay using porcine thyroid cells.
    Kamijo K; Murayama H; Uzu T; Togashi K; Kahaly GJ
    Thyroid; 2010 Aug; 20(8):851-6. PubMed ID: 20615137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a Bridge Immunoassay with Two Bioassays for Thyrotropin Receptor Antibody Detection and Differentiation.
    Allelein S; Diana T; Ehlers M; Kanitz M; Hermsen D; Schott M; Kahaly GJ
    Horm Metab Res; 2019 Jun; 51(6):341-346. PubMed ID: 31207654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras].
    Tahara K; Yamamoto K; Tamura Y; Yoshida S
    Nihon Rinsho; 1994 Apr; 52(4):1031-6. PubMed ID: 7515118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Fiore E; Bucci I; Chamblin T; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
    Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
    Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin receptor autoantibodies recognizing two different epitopes on the TSH receptor: lack of relationship to patient age, sex, and ophthalmopathy.
    Jaume JC; Prummel MF; Wiersinga WM; McLachlan SM; Rapoport B
    Thyroid; 1993; 3(4):291-5. PubMed ID: 7509670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.